We are excited to join the endocrine community at ENDO 2025! Visit us at Medical Booth 1509 or head to our Lilly Congress Hub to explore our obesity research. Learn more: e.lilly/3Iq0gqV

New Results from the ACHIEVE-1 Phase 3 Study of a GLP-1 receptor agonist in early type 2 diabetes Click here to read the full study: e.lilly/4koQ9QF

Thank you to all who joined us in San Francisco, CA at ENDO 2025! Attendees can learn more about the obesity research we presented at our Lilly Congress Hub: e.lilly/4kz1Jsy

Swipe to explore two unique resources: Maria’s case in our ConnectAD Clinical Cases, and Dr. Cohen’s demonstration of effective communication during the diagnosis of mild cognitive impairment due to Alzheimer’s disease. Click to view the cases here: e.lilly/4kvVHsA

Calling all registered DERM2025 Attendees! Join Adam Friedman MD, FAAS, in our upcoming symposium session “Expert to Experts” on Wednesday, July 23rd from 3:30PM-4:00PM. View the full agenda: e.lilly/44vEVoy

Psoriatic arthritis treatment often involves addressing coexisting health issues such as obesity, hypertension, metabolic syndrome, and more as part of a comprehensive care plan. Click here to learn more: e.lilly/4lPW425

Results from the Phase 3 VIVID-1 study on fatigue outcomes in Crohn’s disease now available in the Journal of Crohn’s and Colitis: e.lilly/4lFv8C2

Welcome to AAIC 2025! We're excited to share our latest research in Alzheimer's disease. The Lilly Medical Neuroscience team is ready to answer your questions. Learn more: e.lilly/3HJqyUT

AAIC25 Attendees! Think you can crack the case? Join us for interactive patient case puzzles designed to test your knowledge of Alzheimer’s disease. Work through real-world scenarios in detection, diagnosis, treatment, and monitoring. View Cases: e.lilly/4o20pRN

Now available: The ADjoin study offers 2-year data on an IL-13 inhibitor’s efficacy and safety in treating moderate-to-severe atopic dermatitis. Explore IL-13 inhibitor 2-year AD data from ADjoin here: e.lilly/3GJ2yRA

AAIC2025 in Toronto and online was impactful. Thank you to everyone who joined as we explored the latest in Alzheimer’s and neuroscience research. Attendees can find all disclosures from the Congress on our Lilly Congress Hub: e.lilly/3HJqyUT

New Publication in The Lancet Click here to read the full QWINT-4 phase 3 trial results: e.lilly/4eQCxwa

We are excited to join you at the ADCES Congress in Phoenix, AZ! Join us at Medical Booth 1511 or visit our online Lilly Congress Hub to stay connected with our upcoming science. Learn more: e.lilly/41kTV6L

QWINT-3 is now published in The Lancet Click here to read the full study: e.lilly/40kqcua

Thanks for joining us at ADCES25! Catch up on any research you may have missed or explore the latest diabetes science on the Lilly Medical Congress Hub. Learn more: e.lilly/450sy4o

A focused update to the American Academy of Dermatology’s adult atopic dermatitis guidelines is now available. See the complete update here: e.lilly/45aqSoZ

Join us on 8/21 at 6:00 PM EST as we kick off our webinar series with Dr. Priya Jaisinghani, exploring how shared decision making and personalized strategies can support early glycemic control and optimize patient care in Type 2 Diabetes. Register Here: e.lilly/3HgFQR2

Routine cognitive health assessments can help establish a baseline and prompt earlier detection of cognitive impairment. This resource highlights brief tests and digital tools that may support screening in primary care. Download here: e.lilly/4np7fk7

Join us on August 26 at 7:00 PM EST for this expert-led webcast, The Role of Obesity Care in Daily Practice. Learn about the multifactorial drivers of obesity, and discover strategies to help reduce weight stigma and support quality care. Register Here: e.lilly/4lxbQyd

Download a handout featuring expert consensus on the link between obesity and psoriasis, with literature-based insights and clinical considerations: e.lilly/4eQxvjl